滋利特膠囊３０毫克
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Patient Information leaflet
(PIL)
04-06-2021
Public Assessment Report
(PAR)
01-06-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
STAVUDINE
Available from:
臺灣必治妥施貴寶股份有限公司 台北市松山區健康路156號4樓、5樓 (11922609)
ATC code:
J05AF04
Pharmaceutical form:
膠囊劑
Composition:
STAVUDINE (0818002200) MG
Units in package:
瓶裝
Class:
製 劑
Prescription type:
須由醫師處方使用
Manufactured by:
EMCURE PHARMACEUTICALS USA, INC. 21-B COTTERS LANE EAST BRUNSWICK, NEW JERSEY, 08816, U.S.A. US
Therapeutic area:
stavudine
Therapeutic indications:
治療人類免疫缺乏病毒（ＨＩＶ）感染
Product summary:
註銷日期: 2017/09/27; 註銷理由: 自請註銷; 有效日期: 2017/09/18; 英文品名: ZERIT(STAVUDINE) CAPSULES 30MG
Authorization status:
已註銷
Authorization date:
1997-09-18
Patient Information leaflet
®
°
°
°
°
°
Emcure Pharmaceuticals USA Inc.
21-B Cotters Lane East Brunswick, New Jersey 08816 USA
Aesica Queenborough Limited
North Road, Queenborough, Kent, Me11 5EL, United Kingdom
3040
ZERIT* Capsules 30mg, 40mg
3040
ZERIT* Capsules 30mg, 40mg
_13_
10
11
11.1
_11.3_
12
12.1
13
14.1
14.2
_8.3_
8.2
8.3
_8.4_
11.3
Read the complete document
